U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755371) titled 'A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps' on Aug. 05.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AK139 injection compared with placebo in participants with chronic rhinosinusitis with nasal polyps (CRSwNP) receiving background treatment with mometasone furoate nasal spray (MFNS).

Study Start Date: Aug. 10

Study Type: INTERVENTIONAL

Condition: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Intervent...